Diabetes, metabolic disease, and telomere length
Feifei Cheng
1
,
Luke Carroll
2
,
A. P.S. Kong
3
,
Andrzej Januszewski
2
,
Kwun Kiu Wong
1
,
Alicia J. Jenkins
4, 5
,
R. C.W. Ma
4
Publication type: Journal Article
Publication date: 2021-02-01
scimago Q1
wos Q1
SJR: 12.190
CiteScore: 64.2
Impact factor: 41.8
ISSN: 22138587, 22138595
PubMed ID:
33248477
Endocrinology
Endocrinology, Diabetes and Metabolism
Internal Medicine
Abstract
Summary
Telomeres are regions of repetitive nucleotide sequences at the ends of chromosomes. Telomere length is a marker of DNA damage, which is often considered a biomarker for biological ageing, and has also been linked with cardiovascular disease, diabetes, and cancer. Emerging studies have highlighted the role of genetic and environmental factors, and explored the effect of modulating telomere length. We provide an overview of studies to date on diabetes and telomere length, and compare different methods and assays for evaluating telomere length and telomerase activity. We highlight the limitations of current studies and areas that warrant further research to unravel the link between diabetes and telomere length. The value of adding telomere length to clinical risk factors to improve risk prediction of diabetes and related complications also merits further investigation.Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
8
|
|
|
Frontiers in Endocrinology
8 publications, 5.03%
|
|
|
Journal of Clinical Endocrinology and Metabolism
5 publications, 3.14%
|
|
|
International Journal of Molecular Sciences
4 publications, 2.52%
|
|
|
Nutrients
3 publications, 1.89%
|
|
|
Journal of Clinical Medicine
3 publications, 1.89%
|
|
|
Scientific Reports
3 publications, 1.89%
|
|
|
Ageing Research Reviews
3 publications, 1.89%
|
|
|
Biomolecules
2 publications, 1.26%
|
|
|
Frontiers in Oncology
2 publications, 1.26%
|
|
|
Respiratory Research
2 publications, 1.26%
|
|
|
Reproductive Sciences
2 publications, 1.26%
|
|
|
Frontiers in Genetics
2 publications, 1.26%
|
|
|
Diabetes Research and Clinical Practice
2 publications, 1.26%
|
|
|
BMC Medicine
2 publications, 1.26%
|
|
|
Journal of Hazardous Materials
2 publications, 1.26%
|
|
|
GeroScience
2 publications, 1.26%
|
|
|
Journal of Nutrition, Health and Aging
2 publications, 1.26%
|
|
|
PLoS ONE
2 publications, 1.26%
|
|
|
Antioxidants
2 publications, 1.26%
|
|
|
Cardiovascular Diabetology
2 publications, 1.26%
|
|
|
Journal of Affective Disorders
2 publications, 1.26%
|
|
|
Pediatric Research
2 publications, 1.26%
|
|
|
Life
2 publications, 1.26%
|
|
|
Current Vascular Pharmacology
1 publication, 0.63%
|
|
|
Frontiers in Cardiovascular Medicine
1 publication, 0.63%
|
|
|
Medicine (United States)
1 publication, 0.63%
|
|
|
World Journal of Gastrointestinal Oncology
1 publication, 0.63%
|
|
|
International Journal of Stroke
1 publication, 0.63%
|
|
|
Medicines
1 publication, 0.63%
|
|
|
1
2
3
4
5
6
7
8
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Springer Nature
39 publications, 24.53%
|
|
|
Elsevier
34 publications, 21.38%
|
|
|
MDPI
21 publications, 13.21%
|
|
|
Frontiers Media S.A.
17 publications, 10.69%
|
|
|
Wiley
6 publications, 3.77%
|
|
|
The Endocrine Society
5 publications, 3.14%
|
|
|
SAGE
4 publications, 2.52%
|
|
|
Taylor & Francis
3 publications, 1.89%
|
|
|
BMJ
3 publications, 1.89%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 1.89%
|
|
|
Oxford University Press
3 publications, 1.89%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.26%
|
|
|
Baishideng Publishing Group
2 publications, 1.26%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.26%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.63%
|
|
|
Cambridge University Press
1 publication, 0.63%
|
|
|
Optica Publishing Group
1 publication, 0.63%
|
|
|
Nanjing Medical University
1 publication, 0.63%
|
|
|
American Diabetes Association
1 publication, 0.63%
|
|
|
XMLink
1 publication, 0.63%
|
|
|
Impact Journals
1 publication, 0.63%
|
|
|
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
1 publication, 0.63%
|
|
|
Mary Ann Liebert
1 publication, 0.63%
|
|
|
S. Karger AG
1 publication, 0.63%
|
|
|
American Chemical Society (ACS)
1 publication, 0.63%
|
|
|
NII KPSSZ
1 publication, 0.63%
|
|
|
Edizioni Minerva Medica
1 publication, 0.63%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
159
Total citations:
159
Citations from 2024:
74
(46.55%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Cheng F. et al. Diabetes, metabolic disease, and telomere length // The Lancet Diabetes and Endocrinology. 2021. Vol. 9. No. 2. pp. 117-126.
GOST all authors (up to 50)
Copy
Cheng F., Carroll L., Kong A. P., Januszewski A., Wong K. K., Jenkins A. J., Ma R. C. Diabetes, metabolic disease, and telomere length // The Lancet Diabetes and Endocrinology. 2021. Vol. 9. No. 2. pp. 117-126.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/s2213-8587(20)30365-x
UR - https://doi.org/10.1016/s2213-8587(20)30365-x
TI - Diabetes, metabolic disease, and telomere length
T2 - The Lancet Diabetes and Endocrinology
AU - Cheng, Feifei
AU - Carroll, Luke
AU - Kong, A. P.S.
AU - Januszewski, Andrzej
AU - Wong, Kwun Kiu
AU - Jenkins, Alicia J.
AU - Ma, R. C.W.
PY - 2021
DA - 2021/02/01
PB - Elsevier
SP - 117-126
IS - 2
VL - 9
PMID - 33248477
SN - 2213-8587
SN - 2213-8595
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Cheng,
author = {Feifei Cheng and Luke Carroll and A. P.S. Kong and Andrzej Januszewski and Kwun Kiu Wong and Alicia J. Jenkins and R. C.W. Ma},
title = {Diabetes, metabolic disease, and telomere length},
journal = {The Lancet Diabetes and Endocrinology},
year = {2021},
volume = {9},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/s2213-8587(20)30365-x},
number = {2},
pages = {117--126},
doi = {10.1016/s2213-8587(20)30365-x}
}
Cite this
MLA
Copy
Cheng, Feifei, et al. “Diabetes, metabolic disease, and telomere length.” The Lancet Diabetes and Endocrinology, vol. 9, no. 2, Feb. 2021, pp. 117-126. https://doi.org/10.1016/s2213-8587(20)30365-x.